100 Recruiting Studies Using Lenalidomide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Lenalidomide
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
📍 The University of Arizona Cancer Center - North Campus /ID# 242219 — Tucson, Arizona
Non-Hodgkin Lymphoma
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Relapsed or Refractory Follicular Lymphoma
View Study & Checklist ➔Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Light Chain Deposition Disease
View Study & Checklist ➔A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
📍 Stanford University School of Med /ID# 242809 — Stanford, California
Relapsed/Refractory Multiple Myeloma
View Study & Checklist ➔Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
📍 MorphoSys Research Site — Daphne, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
📍 Southern Cancer Center — Mobile, Alabama
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Aggressive B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
Multiple Myeloma
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
📍 Local Institution - 0131 — Los Angeles, California
Multiple Myeloma
View Study & Checklist ➔A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
📍 Novartis Investigative Site — Camperdown, New South Wales
Follicular Lymphoma (FL)
View Study & Checklist ➔2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist ➔Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Chronic Myelomonocytic Leukemia
View Study & Checklist ➔S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Multiple Myeloma
View Study & Checklist ➔Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Lymphoma
View Study & Checklist ➔Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
📍 Morristown Memorial Hospital — Morristown, New Jersey
Diffuse Large B Cell Lymphoma
View Study & Checklist ➔Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
📍 Roswell Park Cancer Institute — Buffalo, New York
Plasma Cell Myeloma
View Study & Checklist ➔Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
📍 Northern Light Eastern Maine Medical Center — Bangor, Maine
Myeloma, Multiple
View Study & Checklist ➔Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
📍 UCLA Site Number : 8400010 — Los Angeles, California
Plasma Cell Myeloma
View Study & Checklist ➔A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 City of Hope National Medical Center /ID# 273338 — Duarte, California
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
📍 Emory University — Atlanta, Georgia
Grade 3a Follicular Lymphoma
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Ann Arbor Stage I Small Lymphocytic Lymphoma
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
📍 University of Arkansas for Medical Sciences /ID# 243096 — Little Rock, Arkansas
Relapsed/Refractory Multiple Myeloma
View Study & Checklist ➔Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Multiple Myeloma
View Study & Checklist ➔A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
📍 Rocky Mountain Cancer Centers — Aurora, Colorado
Multiple Myeloma
View Study & Checklist ➔A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
📍 John Muir Health Clinical Research Center — Concord, California
Follicular Lymphoma
View Study & Checklist ➔Lenalidomide for Adult Histiocyte Disorders
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Langerhans Cell Histiocytosis (LCH)
View Study & Checklist ➔Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
📍 Emory University — Atlanta, Georgia
Multiple Myeloma
View Study & Checklist ➔Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
📍 Massachusetts General Hospital — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
📍 UCSF — San Francisco, California
Multiple Myeloma
View Study & Checklist ➔A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Multiple Myeloma
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
📍 City of Hope National Medical Center — Duarte, California
Follicular Lymphoma
View Study & Checklist ➔Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
📍 Arizona Oncology Associates, PC - HOPE — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
📍 The University of Chicago — Chicago, Illinois
Myeloma
View Study & Checklist ➔Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
📍 Weill Cornell Medicine — New York, New York
Mantle Cell Lymphoma
View Study & Checklist ➔A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
📍 Children's Hospital Los Angeles — Los Angeles, California
Recurrent Neuroblastoma
View Study & Checklist ➔Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Newly Diagnosed Multiple Myeloma
View Study & Checklist ➔DARA RVD For High Risk SMM
📍 Stamford Hospital — Stamford, Connecticut
High-risk Smoldering Multiple Myeloma
View Study & Checklist ➔Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic Cell Transplantation Recipient
View Study & Checklist ➔Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Anemia
View Study & Checklist ➔Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Plasma Cell Myeloma
View Study & Checklist ➔Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Ann Arbor Stage III Grade 1 Follicular Lymphoma
View Study & Checklist ➔Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
📍 University Of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Multiple Myeloma
View Study & Checklist ➔Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
📍 University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
📍 Moffitt Cancer Center — Tampa, Florida
Smoldering Multiple Myeloma
View Study & Checklist ➔Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
📍 Banner Gateway Medical Center — Gilbert, Arizona
Multiple Myeloma
View Study & Checklist ➔A Study of Daratumumab
📍 University of Miami Sylvester Cancer Center — Miami, Florida
Multiple Myeloma
View Study & Checklist ➔Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
Recurrent Chronic Lymphocytic Leukemia
View Study & Checklist ➔Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma
📍 Research Site — Tucson, Arizona
Non Hodgkin Lymphoma
View Study & Checklist ➔Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
ISS Stage III Plasma Cell Myeloma
View Study & Checklist ➔Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
📍 M D Anderson Cancer Center — Houston, Texas
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
📍 Massachusetts General Hospital — Boston, Massachusetts
Smoldering Multiple Myeloma
View Study & Checklist ➔Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Multiple Myeloma
View Study & Checklist ➔Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
📍 University of Rochester Medical Center — Rochester, New York
Multiple Myeloma
View Study & Checklist ➔A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
📍 University Of California San Diego — San Diego, California
Multiple Myeloma
View Study & Checklist ➔Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔KRDI in Transplant-Eligible MM
📍 Massachusetts General Hospital — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
📍 Providence Alaska Medical Center — Anchorage, Alaska
DS Stage I Multiple Myeloma
View Study & Checklist ➔Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
View Study & Checklist ➔Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
📍 GSK Investigational Site — Westwood, Kansas
Multiple Myeloma
View Study & Checklist ➔MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Multiple Myeloma
View Study & Checklist ➔Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 Providence Hospital — Mobile, Alabama
Multiple Myeloma
View Study & Checklist ➔Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
📍 UCSF Fresno /ID# 264712 — Fresno, California
Follicular Lymphoma (FL)
View Study & Checklist ➔Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
📍 The Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey
Mantle Cell Lymphoma
View Study & Checklist ➔Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
📍 GSK Investigational Site — Atlanta, Georgia
Multiple Myeloma
View Study & Checklist ➔Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
📍 Emory University — Atlanta, Georgia
B-Cell Lymphoma, Unspecified
View Study & Checklist ➔Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
📍 GSK Investigational Site — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma
📍 City of Hope — Duarte, California
Multiple Myeloma
View Study & Checklist ➔Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
DS Stage I Multiple Myeloma
View Study & Checklist ➔A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
📍 University of Miami — Miami, Florida
Multiple Myeloma
View Study & Checklist ➔Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
📍 Weill Cornell Medical College — New York, New York
Multiple Myeloma
View Study & Checklist ➔BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Multiple Myeloma
View Study & Checklist ➔A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Plasmacytoma
View Study & Checklist ➔Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
DS Stage I Multiple Myeloma
View Study & Checklist ➔A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Elimination of Minimal Residual Disease After Transplant
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
Multiple Myeloma
View Study & Checklist ➔Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
📍 Children's Hospital Los Angeles — Los Angeles, California
Neuroblastoma
View Study & Checklist ➔A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
📍 University of Arkansas — Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist ➔Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
📍 Central Alabama Research — Birmingham, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
📍 Ucsf Fresno University of California San Francisco Fresno — Fresno, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔Lenalidomide Maintenance in Plasma Cell Myeloma
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
Plasma Cell Myeloma
View Study & Checklist ➔Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Effusion Lymphoma
View Study & Checklist ➔Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
📍 University of Chicago — Chicago, Illinois
Multiple Myeloma
View Study & Checklist ➔Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
View Study & Checklist ➔A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
📍 Dana Farber Cancer Institute (Data Collection and Specimen Analysis) — Boston, Massachusetts
Mantle Cell Lymphoma
View Study & Checklist ➔Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
📍 O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham — Birmingham, Alabama
Relapsed/Refractory Chronic Lymphocytic Leukemia
View Study & Checklist ➔An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Recurrent B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
📍 The University of Arizona Cancer Center - North Campus /ID# 228862 — Tucson, Arizona
Follicular Lymphoma (FL)
View Study & Checklist ➔Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
📍 City of Hope Medical Center — Duarte, California
Follicular Lymphoma
View Study & Checklist ➔A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
📍 University of Alabama Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
View Study & Checklist ➔SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
📍 Roswell Park Cancer Institute — Buffalo, New York
Partial Response of Multiple Myeloma or Plasma Cell Leukemia
View Study & Checklist ➔Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
📍 City of Hope — Duarte, California
Multiple Myeloma
View Study & Checklist ➔Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Leukemia
View Study & Checklist ➔